Profile
Sector:
HealthcareCountry:
United StatesIPO:
25 September 2013Website:
http://www.evokepharma.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 26 Jun 2024 22:45:00 GMTDividend
Analysts recommendations
Institutional Ownership
EVOK Latest News
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced updates regarding their business and commercial growth strategy.
Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript
SOLANA BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti® (metoclopramide) nasal spray, today announced that the Company is scheduled to release its fourth quarter and full year 2023 on Thursday, March 14, 2024, after the market closes.
What type of business is Evoke Pharma?
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
What sector is Evoke Pharma in?
Evoke Pharma is in the Healthcare sector
What industry is Evoke Pharma in?
Evoke Pharma is in the Drug Manufacturers - Specialty & Generic industry
What country is Evoke Pharma from?
Evoke Pharma is headquartered in United States
When did Evoke Pharma go public?
Evoke Pharma initial public offering (IPO) was on 25 September 2013
What is Evoke Pharma website?
https://www.evokepharma.com
Is Evoke Pharma in the S&P 500?
No, Evoke Pharma is not included in the S&P 500 index
Is Evoke Pharma in the NASDAQ 100?
No, Evoke Pharma is not included in the NASDAQ 100 index
Is Evoke Pharma in the Dow Jones?
No, Evoke Pharma is not included in the Dow Jones index
When does Evoke Pharma report earnings?
The next expected earnings date for Evoke Pharma is 09 August 2024